ClinConnect ClinConnect Logo
Search / Trial NCT06302946

Effect of Neuromuscular Stimulation and Mindfulness Breathing in Patients With Stroke

Launched by CAIRO UNIVERSITY · Mar 7, 2024

Trial Information

Current as of August 20, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying the effects of two different treatments for patients who have had a stroke. Researchers want to see if combining neuromuscular stimulation (a therapy that helps muscles work better) and mindfulness breathing (a relaxation technique) along with traditional physiotherapy can help stroke patients recover more effectively than just using traditional physiotherapy alone. The trial will involve 60 stroke patients who are divided into two groups: one group will receive all three treatments, while the other group will only receive traditional physiotherapy.

To be eligible for this trial, patients should be between 50 and 65 years old and must have been diagnosed with a stroke confirmed by medical imaging tests like CT scans or MRIs. It’s important that participants are stable, can understand the study requirements, and do not have any serious health issues that could interfere with the treatment. If you or someone you know is considering participating, this trial offers a chance to explore new ways to support recovery after a stroke.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * The subject selection will be according to the following criteria:
  • All Patients of this study will be diagnosed as stroke and the diagnosis will be confirmed by computed tomography or MRI (El-Tamawy et al., 2021).
  • Age of patients will be ranged from 50 to 65years (males and females).
  • All patients will be hemodynamically stable.
  • Patients with good cognition that enables them to understand the requirements of the study.
  • Exclusion Criteria:
  • * • The potential participants will be excluded if they meet one of the following criteria:
  • Patients who cannot follow instructions as sensory aphasia, blindness, dementia, and deafness.
  • Patients with any orthopedic, neurological, or chest disorders that affect trunk muscles control or cause respiratory disorders as COPD.
  • Patients with cognitive and psychiatric disorders.
  • Patients with unstable cardiovascular conditions.
  • * Patients with contraindications to neuro electrical stimulation as:
  • Cardiac pace maker.
  • Acute abdominal surgery.

About Cairo University

Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.

Locations

Cairo, Dokki, Egypt

Patients applied

0 patients applied

Trial Officials

marwa elsayed

Principal Investigator

Cairo University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported